Merck’s Vioxx scandal widens: Cherry Picking Studies for Publication

Drug maker knew Vioxx was deadly for years before risk was made public (opinion)

November 25, 2009

NaturalNews

The Vioxx scandal widened this week as new research published in the Archives of Internal Medicine reveals that Vioxx maker Merck held data for three years that proved Vioxx caused an alarming increase in the risk of heart attacks and strokes. And yet Merck chose not to release that data. In fact, it took three more years of patients dying from heart attacks before Vioxx was pulled off the market, and even then, Merck insisted the drug was not dangerous.

This new study was based on a meta-analysis of several unpublished studies that Merck obviously didn’t want to see published in medical journals. Drug companies routinely engage in this subterfuge: They cherry-pick which studies they want published while burying the rest. They also choose which studies to forward to the FDA, all while claiming the whole charade is based on “evidence-based medicine.”

FDA officials conspired with Merck to defame Truth Teller–NEJM credibility

Alliance for Human Research Protection

June 2006

Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers. In this case, Merck and FDA officials colluded to deceive the public about the safety of widely prescribed drugs–in this case, Vioxx. Furthermore, prestigious medical journals publish reports about drug trials whose lethal effects are concealed—in this case, The New England Journal of Medicine.

The drug’s hazards are shown to have been carefully hidden from the public and from prescribing doctors through a coordinated effort by Merck and FDA officials. Bloomberg News reports that Merck has set aside $970 million to defend the Vioxx lawsuits and nothing to cover liability. The company has vowed to fight every case.

Obama Sides With Investors in Merck Lawsuit

Smart Money

By Brent Kendall
Of DOW JONES NEWSWIRES

October 27, 2009

WASHINGTON -(Dow Jones)- The Obama administration sided with investors Monday in a U.S. Supreme Court case that examines whether shareholders of Merck & Co. Inc. (MRK) waited too long to file securities lawsuits alleging the drug maker misrepresented the safety of painkiller drug Vioxx, which it removed from the market in 2004.

Merck Sued for Underhanded Marketing by Kentucky Attorney General

InjuryBoard.com
October 1, 2009

Posted by Mike Ferrara

Kentucky Attorney General Jack Conway has filed suit in Franklin Circuit Court against pharma giant Merck for violating Kentucky’s Consumer Protection Act in connection with Vioxx, the blockbuster painkiller that caused strokes and heart attacks, and was withdrawn from the market in September 2004.

Gardasil Dad Keeps Asking Questions & Demanding Answers

15th September 2009

Dr B McNamee

CEO and Managing Director

CSL

45 Polar Road

Parkville

Victoria 3052

Dear Dr McNamee

I am writing to you directly to express my considerable concerns over Gardasil and the level of extreme adverse reactions being experienced in this country and elsewhere following the administration of the vaccine, one being my own daughter Chescia.

Chescia had her 2nd shot in May 2009 and almost immediately had a severe response – I wont bore you with details, but she is now in St Vincent’s Hospital under the care of Professor Ron Penny – the immunologist, who has privately advised us that he believes Gardasil triggered her issues (as did her Neurologist Dr Garrick) but cannot prove it.

Case shines light on Merck

The Australian Business with The Wall Street Journal
June 27, 2009

WARREN Back received his instructions by telephone at 5.30pm on September 29, 2004, sitting in his nondescript hotel room in the US city of Philadelphia. He was told to collect a series of envelopes and distribute them to his international colleagues who had already gathered in the hotel for a conference, and keep one for himself.

Inside his envelope was a typed message telling him to go back to his hotel room and wait by the phone to receive a call from his superiors. He took the call two hours later and was stunned by what he heard.

This may sound like an elaborate plot of a spy thriller but Back was no CIA agent and he was not trading state secrets. Back was the Australian regulatory affairs manager for pharmaceutical giant Merck & Co and he was being informed that its blockbuster anti-arthritis drug Vioxx was being voluntarily recalled amid concerns it could increase the risk of heart attack.

What To Do About Dysfunctional FDA

From drug safety snafus dating as far back as Vioxx to last year’s heparin scandal, from melamine in dog food to salmonella in peanut butter, the FDA has spent beaucoups hours fighting fires. Meanwhile, dispassionate observers such as the Government Accountability Office have advised big-time changes for the agency, and its own Science Board said it was so seriously understaffed and underfunded that it couldn’t ensure the safety of food or drugs in the U.S.

HPV-Vaccine, How We Got Here

perry

markers before the trial. The study was selected for women who showed some sort of robust natural immunity that kept them from expressing the HPV markers. 859 were excluded from the final data analysis for technical reasons and the vast majority were found to be infected with HPV-16 before getting the vaccine.

Drug company behind Gardasil caught up in marketing deception

Semper Vita
May 11, 2009

THE world’s largest medical publisher, Elsevier, has expressed embarrassment at its role in a deceptive marketing ploy by the giant drug company Merck after it was revealed in a Melbourne court.

Elsevier said it had failed to meet its own “high standards for disclosure” when it produced a magazine that pretended to be an independent scientific journal but was actually a marketing front for Merck’s anti-inflammatory drug Vioxx.

Mandatory Childhood Vaccine Legislation Ignores The Contaminated Culture That Created It

Children of God for Life
By Pam Martens
2007
A national furor has erupted over another executive order. This time, it’s not the President of the United States bypassing the legislative branch of government to pass laws, it’s the Governor of one of the three most populated states in the country. Rick Perry, Governor of Texas, has signed an order making it mandatory for 11 and 12 year old girls to be injected with a 3-shot regimen vaccine that’s been on the market less than 9 months. Ostensibly, the vaccine is to prevent some strains of human papillomavirus (HPV) that may cause cervical cancer, a cancer that occurs annually in less than one-tenth of one percent of women in the U.S.